yr 〜
yr

Search results 17

癌化学療法施行時の担癌宿主における免疫反応の解明

癌化学療法施行時の担癌宿主における免疫反応の解明
Paper図書
藤本, 敏博, 金沢大学2000-2001<Y151-H12671212>
National Diet Library
  • Subject HeadingIrinotecan (CPT-11) OK-432 Th1 IL-12 imm...

Useful Parameters in Dynamic Contrast-enhanced Ultrasonography for Identifying Early Response to Chemotherapy in a Rat Liver Tumor Model

Useful Parameters in Dynamic Contrast-enhanced Ultrasonography for Identifying Early Response to Chemotherapy in a Rat Liver Tumor Model
Digital博士論文障害者向け資料あり
Taiji, Ryosuke, Nishiofuku, Hideyuki, Tanaka, Toshihiro, Minamiguchi, Kiyoyuki, Fukuoka, Yasushi, Saito, Natsuhiko, Taguchi, Hidehiko, Matsumoto, Takeshi, Marugami, Nagaaki, Hirai, Toshiko, Kichikawa, KimihikoScientific Scholar2021-03-15
National Diet Library
  • Subject HeadingUltrasonography Colon cancer Rats Biomarkers Irinotecan Contrast media
  • Note (General)...ly response to irinotecan in a rat liver...... 6; treatment: Irinotecan,n = 14) regard......ly response to irinotecan. 博士（医学）・甲第879号・令和5年3月15日 ©202...

Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan

Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan
Digital博士論文障害者向け資料あり
緒方, 傑2023-01-31
National Diet Library
  • Subject HeadingChinese hamster ovary cell cancer chemotherapy drug resistance genetic mutation irinotecan

ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan. 12 4

ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan. 12 4
Digital博士論文障害者向け資料あり
TUY, Hoang DinhSpandidos publications2016-08-03Oncology letters
National Diet Library
  • Subject Headingcolorectal adenocarcinoma ABCG2 irinotecan drug resistance
  • Note (General)Irinotecan is a key drug ......he efficacy of irinotecan is not suffici......oresistance to irinotecan. Using the res...... metabolite of irinotecan), was investig......s, 17 received irinotecan-based chemothe...... resistance to irinotecan-based chemothe...... resistance to irinotecan-based chemotherapy for patien...

PhaseⅡ trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA 10 3

PhaseⅡ trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA 10 3
Digital博士論文障害者向け資料あり
竹本, 真之輔John Wiley & Sons Australia, Ltd2019-06-05Thoracic Cancer
National Diet Library
  • Subject Heading...tation group 1 irinotecan non-small cell lung cancer pa...

Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancer 78 2

Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancer 78 2
Digital博士論文障害者向け資料あり
Takaoka, Toshi, Kimura, Tetsuo, Shimoyama, Rai, Kawamoto, Shunji, Sakamoto, Kazuki, Goda, Fuminori, Miyamoto, Hiroshi, Negoro, Yuji, Tsuji, Akihito, Yoshizaki, Koji, Goji, Takahiro, Kitamura, Shinji, Yano, Hiromi, Okamoto, Koichi, Kimura, Masako, Okahisa, Toshiya, Muguruma, Naoki, Niitsu, Yoshiro, Takayama, TetsujiSpringer Berlin Heidelberg2016-06-24Cancer Chemotherapy and Pharmacology
National Diet Library
  • Subject Headingcolorectal cancer IRIS panitumumab second-line therapy chemotherapy irinotecan S-1
  • Note (General)Background Irinotecan plus S-1 (IRIS......b (6mg/kg) and irinotecan (100mg/m2) on days 1 and 15 a...

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
Digital博士論文障害者向け資料あり
Sawano, Takeyuki2015-09-30
National Diet Library
  • Subject Heading...teatohepatitis irinotecan 医学
  • Note (General)...athogenesis of irinotecan-associated fat......ered 200 mg/kg irinotecan by intraperito...... day 18. Thus, irinotecan-induced liver steatosis was p...
  • Alternative TitleIrinotecan投与によるラット肝の脂肪化誘発......脂肪酸合成酵素陽性細胞の出現 Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソ...

Useful Parameters in Dynamic Contrast-enhanced Ultrasonography for Identifying Early Response to Chemotherapy in a Rat Liver Tumor Model

Useful Parameters in Dynamic Contrast-enhanced Ultrasonography for Identifying Early Response to Chemotherapy in a Rat Liver Tumor Model
Digital博士論文
Taiji, Ryosuke, Nishiofuku, Hideyuki, Tanaka, Toshihiro, Minamiguchi, Kiyoyuki, Fukuoka, Yasushi, Saito, Natsuhiko, Taguchi, Hidehiko, Matsumoto, Takeshi, Marugami, Nagaaki, Hirai, Toshiko, Kichikawa, KimihikoScientific Scholar2021-03-15Journal of clinical imaging science11p.Article No.15-
Available onlineOther Libraries in Japan
  • Subject HeadingUltrasonography Colon cancer Rats Biomarkers Irinotecan Contrast media
  • Note (General)...ly response to irinotecan in a rat liver...... 6; treatment: Irinotecan, n = 14) regar......ly response to irinotecan. 博士（医学）・甲第879号・令和5年3月15日 ©202...

ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.

ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.
Digital博士論文
TUY, Hoang DinhSpandidos publications2016-08-03Oncology letters12 4p.2752-2760
Available onlineOther Libraries in Japan
  • Summary, etc.Irinotecan is a key drug ......he efficacy of irinotecan is not suffici......oresistance to irinotecan. Using the res...... metabolite of irinotecan), was investig......s, 17 received irinotecan-based chemothe...... resistance to irinotecan-based chemothe...... resistance to irinotecan-based chemotherapy for patien...
  • Subject Headingcolorectal adenocarcinoma ABCG2 irinotecan drug resistance

PhaseⅡ trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA

PhaseⅡ trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA
Digital博士論文
竹本, 真之輔John Wiley & Sons Australia, Ltd2019-06-05Thoracic Cancer10 3p.452-458
Available onlineOther Libraries in Japan
  • Summary, etc....let regimen of irinotecan and paclitaxel plus bevacizum...
  • Subject Heading...tation group 1 irinotecan non-small cell lung cancer pa...

Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancer

Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancer
Digital博士論文
髙岡, 遠, 木村, 哲夫, シモヤマ, ライ, カワモト, シュンジ, サカモト, カズキ, ゴウダ, フミノリ, 宮本, 弘志, ネゴロ, ユウジ, ツジ, アキヒト, ヨシザキ, コウジ, 郷司, 敬洋, 北村, 晋志, 矢野, 弘美, 岡本, 耕一, 木村, 雅子, 岡久, 稔也, 六車, 直樹, ニイツ, ヨシロウ, 高山, 哲治Springer Berlin Heidelberg2016-06-24Cancer Chemotherapy and Pharmacology78 2p.397-403
Available onlineOther Libraries in Japan
  • Summary, etc.Background Irinotecan plus S-1 (IRIS......b (6mg/kg) and irinotecan (100mg/m2) on days 1 and 15 a...
  • Subject Headingcolorectal cancer IRIS panitumumab second-line therapy chemotherapy irinotecan S-1

転移性大腸がんに対するベバシズマブ併用療法選択のためのバイオマーカーの探索的研究

転移性大腸がんに対するベバシズマブ併用療法選択のためのバイオマーカーの探索的研究
Digital文書・図像類
藤田, 至彦近畿大学2020科学研究費助成事業研究成果報告書 (2019)p.1-7
Other Libraries in Japan
  • Summary, etc....e treated with irinotecan(iri)-based than those with ox...
  • Subject Heading進行性大腸がん irinotecan oxaliplatin bevacizumab CGH ア...

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
Digital博士論文
Sawano, Takeyuki2015-09-30p.1-33
Available onlineOther Libraries in Japan
  • Summary, etc....athogenesis of irinotecan-associated fat......ered 200 mg/kg irinotecan by intraperito...... day 18. Thus, irinotecan-induced liver steatosis was p...
  • Subject Heading...teatohepatitis irinotecan
  • Alternative TitleIrinotecan投与によるラット肝の脂肪化誘発......脂肪酸合成酵素陽性細胞の出現 Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソ...

癌化学療法施行時の担癌宿主における免疫反応の解明

癌化学療法施行時の担癌宿主における免疫反応の解明
Digital文書・図像類
藤本, 敏博, Fujimoto, Toshihiro2003-09-16平成13(2001)年度 科学研究費補助金 基盤研究(C) 研究概要 = 2001 Research Project Summary2000 – 2001p.2p.-
Other Libraries in Japan
  • Subject HeadingIrinotecan(CPT-11) OK-432 Th1 IL-12 immu...
  • Note (General)... lower dose of irinotecan (CPT-ll) exerts larger antitu...

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
Digital博士論文
山﨑, 健太郎
Available onlineOther Libraries in Japan
  • Subject Headingirinotecan oxaliplatin bevacizumab color...

Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer

Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer
Paper博士論文
大塚, 弘子
Other Libraries in Japan
  • Subject Headingbreast cancer S-1 irinotecan UGT1A1

Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan

Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan
Digital博士論文
緒方, 傑
Available onlineOther Libraries in Japan
  • Subject HeadingChinese hamster ovary cell cancer chemotherapy drug resistance genetic mutation irinotecan

Reached to the end of result.